Sterile Powder Filling Machine Market, by Production Rate (Production Rate: 20 to 60 Fills/Minute, Production Rate: 50 to 100 Fills/Minute, Production Rate: 100 to 300 Fills/Minute, Production Rate: 300 to 500 Fills/Minute), by Product Type (Anti-cancer Drugs, Nuclear Medicine, Others (Antifungals, Antibiotics, and other Pharmaceutical Products)), by Packaging Type (Vials, Cartridges, Syringes, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Sterile powder filling machine are designed to fill powder injection vials uses in pharmaceuticals. Sterile powder filling machine is the instrument which can do filling and stoppering operations on same platform. All parts of this machine are made from stainless steel or U.S. Food and Drug Administration approved materials for Good Manufacturing Practices (GMP) compliance.
Features of Sterile Powder Filling Machine
- Multiple dosing system
- High volumetric filling accuracy ± 1% of the uniform density injectable powder can be
- Individual drive for the filling and sealing to match the speed of filling and sealing
- All parts are easily removable for autoclaving/ sterilization
- Digital counter for counting production output.
Increasing product launch by the key market players is expected to drive the growth of global sterile powder filling machines market, over the forecast period. For instance, in 2018, NJM, a ProMach product brand, launched Dara HSL-PP/4, a high-speed aseptic filling and closing machine for vials, at Healthcare Packaging Expo Booth. The machine can run upto 200 vials per minute using four heads at each station, and this system offers 100% in-process weight control, low maintenance, simple change overs, and proper flexibility.
Key players are involved in expansion of production units is expected to drive the growth of global sterile powder filling machines market, over the forecast period. For instance, in May 2021, OPTIMA packaging group GmbH, a machinery industry company, build a CSPE Center at its headquarters in Schwaebisch. Building of this center expanded OPTIMA’s production area by around 46,000 square feet, to be used for assembly and comprehensive commissioning of pharmaceutical filling lines.
Key features of the study:
- This report provides an in-depth analysis of the global sterile powder filling machines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global sterile powder filling machines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Duke Technologies, Adinath International, Multi Pack Machinery, Harsiddh Engineering, SB Machines, OPTIMA Packaging, Ambica Pharma Machines Pvt. Ltd, N.K. INDUSTRIES, COZZOLI MACHINE COMPANY, METACRAFTS Packaging Machinery, Romaco S.r.l., Lodha International LLP, SHIBUYA CORPORATION, MAR USA Inc., PPS A/S, Parth Engineers & Consultant, Bausch + Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG, Syntegon, DEC Group, Dosa Srl, Harro Höfliger Verpackungsmaschinen GmbH, Tofflon Science, M&O Perry Industries, Inc. and others prominent players
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global sterile powder filling machines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sterile powder filling machines market.
- Global Sterile Powder Filling Machines Market, By Production Rate:
- Production Rate: 20 to 60 Fills/Minute
- Production Rate: 50 to 100 Fills/Minute
- Production Rate: 100 to 300 Fills/Minute
- Production Rate: 300 to 500 Fills/Minute
- Global Sterile Powder Filling Machines Market, By Product Type:
- Anti-cancer Drugs
- Nuclear Medicine
- Others (Antifungals, Antibiotics, and other Pharmaceutical Products)
- Global Sterile Powder Filling Machines Market, By Packaging Type:
- Vials
- Cartridges
- Syringes
- Others
- Global Sterile Powder Filling Machines Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Duke Technologies *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Adinath International
- Multi Pack Machinery
- Harsiddh Engineering
- SB Machines
- OPTIMA Packaging
- Ambica Pharma Machines Pvt. Ltd
- K. INDUSTRIES
- COZZOLI MACHINE COMPANY
- METACRAFTS Packaging Machinery
- Romaco S.r.l.
- Lodha International LLP
- SHIBUYA CORPORATION
- MAR USA Inc.
- PPS A/S
- Parth Engineers & Consultant
- Bausch + Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG
- Syntegon
- DEC Group
- Dosa Srl
- Harro Höfliger Verpackungsmaschinen GmbH
- Tofflon Science
- M&O Perry Industries, Inc.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
- Epidemiology
- 4. Global Endocrine Therapy Drugs (ETDs) Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- 5. Global Endocrine Therapy Drugs (ETDs) Market, By Drug Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Anti-diabetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Anti-osteoporosis Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Contraceptive Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Breast Cancer Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others (Menopause Drugs, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 6. Global Endocrine Therapy Drugs (ETDs) Market, By Application, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Contraception
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others (Gender Reassignment Surgery, Hypothyroidism, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 7. Global Endocrine Therapy Drugs (ETDs) Market, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 8. Global Endocrine Therapy Drugs (ETDs) Market, By Region, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- North America
- Market Size and Forecast, By Drug Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Novo Nordisk A/S
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca
- Generex Biotechnology
- Orion Pharma AB
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche
- Hisamitsu Pharmaceutical Co.,Inc.
- Bayer AG
- Eli Lilly and Company
- Abbott
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- TherapeuticsMD, Inc.
- Pfizer Inc.
- Allergan
- BioSante Pharmaceuticals
- Amgen Inc.
- Noven Pharmaceuticals, Inc.
- QuatRx Pharmaceuticals
- Analyst Views
- 10. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 32 market data tables and 27 figures on "Global Endocrine Therapy Drugs (ETDs) Market” - forecast to 2030
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook